-
Coumadin®: Discontinuation of Sale
Dr. Stephan Moll and Beth Waldron write (last updated April 28, 2020): The company making Coumadin® (warfarin sodium) tablets, Bristol-Myers Squibb (BMS), announced that it will discontinue the sale and distribution of Coumadin® (see the FDA filing here). A memo on the BMS website says: “all strengths of Coumadin® (warfarin sodium) tablets will be discontinued…
-
INR Self-Testing
Stephan Moll, MD writes… A detailed, practical discussion on INR self-testing for patients is available here, addressing: Reasons to do INR self-testing Which patients are suitable What INR home monitoring devices are available Whether the devices give reliable INR results Whether insurance companies pay for them
-
How Often Should the INR be Tested?
-
INR Patient Self-Testing
-
Alcohol and Warfarin or Pradaxa
-
Alcohol and Blood Thinners (Warfarin, Pradaxa)
-
Coumadin Clinics – Finding One Near You
If you are on warfarin (Coumadin®, Jantoven®) you need to be followed in a structured way to optimize your warfarin therapy and minimize the risk for bleeding and clotting. The “thinness” of your blood needs to be determined on a regular basis with a test called INR (International Normalized Ratio; also referred to as PT, protime,…
-
Anticoagulation Clinics – Finding One for Your Patient
Patients on warfarin need to be followed in a systematic way to optimize safety and efficacy of therapy [ref 1]. While smaller-volume physician practices may well have appropriate criteria in place, structured anticoagulation clinics often have the expertise and resources for optimal anticoagulation management. The location of a number of anticoagulation clinics in the U.S.…
